Feb 24, 2021 / 08:00PM GMT
Ami Fadia - SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst
Good afternoon, everyone. Welcome to the next session on Ardelyx. As a reminder, I'm Ami Fadia. I cover biopharma and generics at SVB Leerink. And if you have any questions that you'd like me to ask during the conversation, please feel free to send it over through the dashboard.
It's my pleasure to have Mike Raab, who's the President and CEO of the company today with me. Mike, thank you for taking the time for doing this. Maybe if we could -- if I could ask you to just kick us off with giving an overview of the company, your lead product and the other therapeutic areas you're looking to explore?
Michael G. Raab - Ardelyx, Inc. - President, CEO & Director
Sure. Well, thank you, Ami. I really appreciate the invitation, and we've had a great day on Zoom meeting with a lot of a bunch of investors. So really appreciate the invite from you and SVB.
So we've created Ardelyx in 2007 to do exactly what we're about to demonstrate with 2 months and 5
Ardelyx Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 25, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers